|
Name |
Aurasperone B
|
Molecular Formula | C32H30O12 | |
IUPAC Name* |
7-(2,5-dihydroxy-6,8-dimethoxy-2-methyl-4-oxo-3H-benzo[g]chromen-10-yl)-2,5-dihydroxy-6,8-dimethoxy-2-methyl-3H-benzo[g]chromen-4-one
|
|
SMILES |
CC1(CC(=O)C2=C(O1)C=C3C=C(C(=C(C3=C2O)OC)C4=C5C(=C(C6=C4C=C(C=C6OC)OC)O)C(=O)CC(O5)(C)O)OC)O
|
|
InChI |
InChI=1S/C32H30O12/c1-31(37)11-16(33)24-20(43-31)8-13-7-18(40-4)26(29(42-6)21(13)27(24)35)23-15-9-14(39-3)10-19(41-5)22(15)28(36)25-17(34)12-32(2,38)44-30(23)25/h7-10,35-38H,11-12H2,1-6H3
|
|
InChIKey |
VIFQAHKDYKZMMS-UHFFFAOYSA-N
|
|
Synonyms |
Aurasperone B; 41689-67-2; C0NK50O4Q6; 7-(2,5-dihydroxy-6,8-dimethoxy-2-methyl-4-oxo-3H-benzo[g]chromen-10-yl)-2,5-dihydroxy-6,8-dimethoxy-2-methyl-3H-benzo[g]chromen-4-one; 2,2',5,5'-tetrahydroxy-6,6',8,8'-tetramethoxy-2,2'-dimethyl-2,2',3,3'-tetrahydro-4H,4'H-[7,10'-binaphtho[2,3-b]pyran]-4,4'-dione; UNII-C0NK50O4Q6; Aurosperone B; MLS004256129; DTXSID40961904; CHEBI:133756; SMR003081014; Q27275021; (7,10'-BI-4H-NAPHTHO(2,3-B)PYRAN)-4,4'-DIONE, 2,2',3,3'-TETRAHYDRO-2,2',5,5'-TETRAHYDROXY-6,6',8,8'-TETRAMETHOXY-2,2'-DIMETHYL-; 2,2',3,3'-TETRAHYDRO-2,2',5,5'-TETRAHYDROXY-6,6',8,8'-TETRAMETHOXY-2,2'-DIMETHYL(7,10'-BI-4H-NAPHTHO(2,3-B)PYRAN)-4,4'-DIONE; 2,2',3,3'-TETRAHYDRO-2,2',5,5'-TETRAHYDROXY-6,6',8,8'-TETRAMETHOXY-2,2'-DIMETHYL(7,10'-BI-4H-NAPHTHO(2,3-B)PYRAN)-4,4'-DIONE, (S)-
|
|
CAS | 41689-67-2 | |
PubChem CID | 179522 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 606.6 | ALogp: | 4.6 |
HBD: | 4 | HBA: | 12 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 170.0 | Aromatic Rings: | 6 |
Heavy Atoms: | 44 | QED Weighted: | 0.241 |
Caco-2 Permeability: | -5.272 | MDCK Permeability: | 0.00002140 |
Pgp-inhibitor: | 0.986 | Pgp-substrate: | 0.005 |
Human Intestinal Absorption (HIA): | 0.519 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.004 | Plasma Protein Binding (PPB): | 69.54% |
Volume Distribution (VD): | 0.846 | Fu: | 29.83% |
CYP1A2-inhibitor: | 0.146 | CYP1A2-substrate: | 0.978 |
CYP2C19-inhibitor: | 0.04 | CYP2C19-substrate: | 0.67 |
CYP2C9-inhibitor: | 0.294 | CYP2C9-substrate: | 0.752 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.262 |
CYP3A4-inhibitor: | 0.191 | CYP3A4-substrate: | 0.34 |
Clearance (CL): | 8.257 | Half-life (T1/2): | 0.087 |
hERG Blockers: | 0.018 | Human Hepatotoxicity (H-HT): | 0.135 |
Drug-inuced Liver Injury (DILI): | 0.97 | AMES Toxicity: | 0.101 |
Rat Oral Acute Toxicity: | 0.071 | Maximum Recommended Daily Dose: | 0.157 |
Skin Sensitization: | 0.049 | Carcinogencity: | 0.012 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.013 |
Respiratory Toxicity: | 0.083 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000969 | 0.881 | D06GCK | 0.303 | ||||
ENC002364 | 0.818 | D02LZB | 0.283 | ||||
ENC000984 | 0.737 | D09DHY | 0.282 | ||||
ENC003149 | 0.737 | D0V8HJ | 0.271 | ||||
ENC003048 | 0.712 | D0C1SF | 0.267 | ||||
ENC005171 | 0.679 | D0D4HN | 0.265 | ||||
ENC005172 | 0.667 | D0Y6CE | 0.252 | ||||
ENC003508 | 0.655 | D03RTK | 0.249 | ||||
ENC002884 | 0.655 | D0NJ3V | 0.248 | ||||
ENC005776 | 0.655 | D0V6OA | 0.247 |